Showing results (71-80 of 175) with videos related to
Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppressionR M Gorczynski, M Kennedy, A CiampiImmunology|December 1, 1979
MHC restriction of murine T lymphocyte reactivity analysed by growth of bone marrow cells in vitro on thymus epithelial monolayersR M Gorczynski, B Khomasurya, S MacraeAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 13, 2019
Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory networkR M Gorczynski, T Maqbool, G HoffmannImmunology|August 1, 1984
Altered lymphocyte recognition repertoire during ageing. III. Changes in MHC restriction patterns in parental T lymphocytes and diminution in T suppressor functionR M Gorczynski, M Kennedy, S MacRaeJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1987
T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusionR M Gorczynski, M Boulanger, C LauJournal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivoR M Gorczynski, K Yu, D ClarkBiochimica Et Biophysica Acta|January 20, 1998
Cloning and characterization of the murine homologue of the rat/human MRC OX-2 geneZ Chen, H Zeng, R M GorczynskiInternational Immunology|February 3, 2005
Synthetic peptides from the N-terminal regions of CD200 and CD200R1 modulate immunosuppressive and anti-inflammatory effects of CD200-CD200R1 interactionDang-Xiao Chen, Hao He, R M GorczynskiCellular Immunology|November 25, 1998
The function of TGF-beta-mediated innocent bystander suppression associated with physiological self-tolerance in vivoY T Teng, R M Gorczynski, N HozumiDiabetes Research and Clinical Practice|March 27, 2012
Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patientsA Bisgin, A D Yalcin, R M GorczynskiPageof 18